Atorvastatin/aspirin/ramipril

Drug Profile

Atorvastatin/aspirin/ramipril

Alternative Names: Aspirin/ramipril/atorvastatin; Atorvastatin/acetylsalicylic acid/ramipril; Atorvastatin/ASA/ramipril; Ramipril/atorvastatin/aspirin; Trinomia

Latest Information Update: 24 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferrer
  • Class Heterocyclic bicyclo compounds; Naphthalenes; Nonsteroidal anti-inflammatories; Salicylates; Small molecules
  • Mechanism of Action ACE inhibitors; Cyclooxygenase inhibitors; HMG-CoA reductase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Cardiovascular disorders; Myocardial infarction
  • Phase II Hypertension

Most Recent Events

  • 20 Feb 2017 Phase-III clinical trials in Cardiovascular disorders (Prevention) in Spain (PO) (EudraCT2016-004015-13)
  • 11 Mar 2016 Phase-III SECURE trial in Myocardial infarction in Czech Republic (PO) (EudraCT2015-002868-17)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top